摘要:
The present invention relates to 2-(Pyrimidin-5-yl)-thiopyrimidine derivatives as Hsp70 and Hsc70 modulators for the treatment of proliferative disorders. (Fig. 2)
摘要:
The present invention relates to 2-(Pyrimidin-5-yl)-thiopyrimidine derivatives as Hsp70 and Hsc70 modulators for the treatment of proliferative disorders.
摘要:
This invention provides a process for providing phosphoramidate derivatives, comprising performing a nucleophilic substitution reaction at phosphorous, where a phosphoryl chloride derivative is reacted with an oxime derivative to provide activated phosphoramidate intermediates, the intermediates find utility in a second nucleophilic substitution reaction where an activated phosphoramidate is reacted with a primary alcohol-containing sugar derivative, wherein the product of the reaction is sofosbuvir.
摘要:
Endothelin receptor antagonist nitroderivatives of general formula (I) having an improved pharmacological activity compared with their parent compounds. They can be employed for treating or preventing endothelial-related disorders, renal, pulmonary, cardiac and vascular diseases, and inflammatory processes.
摘要:
Compounds of formula (1), pharmaceutically acceptable salts, solvates and in vivo hydrolysable esters thereof, have activity as pharmaceuticals, in particular as modulators of chemokine receptor (especially CXCR2) activity, and may be in the treatment (therapeutic or prophylactic) of conditions/diseases in human and non-human animals which are exacerbated or caused by excessive or unregulated production of chemokines.
摘要:
The invention provides cytokine production inhibitors useful as preventive or therapeutic agents for diseases accompanied with abnormally enhanced immune function. Cytokine production inhibitors containing as the active ingredient thioamides represented by the general formula (I) or salts thereof: wherein A is N, NO, C-NO2, or C-CN; Hal is halogeno; M1 is alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, a heterocycle, amino, O, S, SO, or SO2; M2 is amino, O, S, or a single bond; R1 is halogeno, alkyl, or the like; R2 R3, R4 and R5 are each independently H, alkyl, or the like; R6 is halogeno, alkyl, or the like; Cy is cycloalkyl, cycloalkenyl, aryl, or a heterocycle; k, p and q are each independently an integer of 0 to 3; and r is an integer of 0 to 5.
摘要翻译:提供细胞因子产生抑制剂,作为伴有过度活化免疫功能的疾病的预防或治疗药物。 含有式(I)所示的硫代酰胺化合物或其盐作为活性成分的细胞因子产生抑制剂:其中A为N,NO,C-NO 2或C-CN; 卤素是卤素; M 1是烷基,烯基,炔基,环烷基,环烯基,芳基,杂环基,氨基,O,S,SO或SO 2; M 2是氨基,O,S或单键; R 1是卤素,烷基等; R 2,R 3,R 4和R 5各自独立地为H,烷基等; R 6是卤素,烷基等; Cy是环烷基,环烯基,芳基或杂环基; k,p和q各自独立地为0〜3的整数; r为0〜5的整数。